Who founded Renovo Rx?

Renovo Rx was founded by Ramtin Agah.

Who are Renovo Rx's investors?

Renovo Rx's investors include Astia, Plug and Play Ventures, Sand Hill Angels.

How much funding has Renovo Rx raised?

Renovo Rx has disclosed $37.7M raised across 5 of its 7 known rounds.

Where is Renovo Rx headquartered?

Renovo Rx is headquartered in Mountain View, US.

Renovo Rx

NASDAQ: RNXT

Mountain View, US · Delaware corporation · 3 known investors

Find your way into Renovo Rx

Paths you didn't know you had: your email and LinkedIn already hold routes to the Renovo Rx team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

RenovoRx is a life sciences company developing targeted drug delivery for cancer treatment, including its TAMP therapy approach. It operates as a publicly listed biopharmaceutical/medical device company focused on oncology.

Biotech Healthtech Medical Devices

Founders & leadership

Ramtin Agah Founder · Chief Medical OfficerRamtin Agah is a physician with background in medical devices, oncology, and healthcare information technology who trained at Cleveland Clinic and UCSF. He is Executive Officer of RenovoRx, which develops targeted oncology therapies and the RenovoCath, an FDA-cleared intra-arterial chemotherapy delivery device.

Shaun R. Bagai CEOShaun R. Bagai is an executive with experience in medical technology, including prior leadership roles in sales, marketing, clinical research, and physician training at both large corporations and growth-stage companies. He serves as Executive Officer and Director at RenovoRx, which develops targeted oncology therapies and the RenovoCath drug-delivery device for intra-arterial chemotherapy.

Leesa Gentry Chief Clinical OfficerLeesa Gentry is a clinical development executive with three decades of experience in therapeutic development and commercialization, including leadership roles in infectious disease programs, regulatory strategy, and clinical trial operations across biotech and pharmaceutical organizations.

Mark Voll Chief Financial OfficerMark Voll is an executive with over 30 years of experience as a CFO at technology companies, including early-stage startups and public corporations, and has overseen multiple initial public offerings. He serves as Executive Officer at RenovoRx, which develops targeted oncology therapies and the RenovoCath drug-delivery device for intra-arterial chemotherapy in cancer treatment.

Kamran Najmabadi FounderKamran Najmabadi brings experience in product development, operations, and strategy across the medical device and consumer electronics sectors, with background in electro-mechanical systems and product lifecycle management.

Board

Klaus HambuechenBoard director

Kirsten Angela MacfarlaneBoard director

Laurence J. MartonBoard director

Una S. RyanBoard director

Robert J. SpiegelBoard director

Investors · 3

Astialisted by AstiaSilicon Valley

Plug and Play Ventureslisted by Plug and Play VenturesSilicon Valley · $50K – $400K

How we know: plugandplaytechcenter.com · Not right? Tell us

Sand Hill Angelslisted by Sand Hill AngelsMenlo Park · $50K – $2M

How we know: sandhillangels.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$37.7M disclosed across 5 of 7 rounds · 1900–2026

▶$10MraisedApr 2026 · 16 investors · Biotechnology

Rule 506(b)